Philips Recognized for the Thirteenth Consecutive Year Among Global Innovators
Royal Philips has been included in the Clarivate Top 100 Global Innovator 2026 ranking, according to the press release published this Tuesday. The Dutch medical technology company ranks at the top among firms in the sector.
Benchmarking Innovation
The ranking established by Clarivate is based on a comparative analysis of global invention data and assesses the strength of each patented idea, the company indicates. This distinction comes as Philips invests more than 1.7 billion euros annually in research and development, which is about 9% of its revenue. According to the company, this level of investment is among the highest in the sector. Roy Jakobs, CEO of Royal Philips, stated that this recognition reflects the company's commitment to patient-centered and evolving innovation.
Advancing Medical Technology
According to the press release, Philips is developing solutions that combine artificial intelligence, advanced imaging, and connected platforms. These technologies aim to support more accurate diagnostics, simplify clinical workflows, and enable patients to proactively manage their health. The company operates in both professional health and consumer health domains, the statement specifies.
Corporate Footprint and Financial Performance
Royal Philips, headquartered in the Netherlands, employs about 67,000 people and operates in over 100 countries, according to the provided information. The group generated a revenue of 18 billion euros in 2024. The company is listed on the Amsterdam Stock Exchange under the ticker PHIA and on the New York Stock Exchange under the symbol PHG. Its operations encompass diagnostic imaging, ultrasound, image-guided therapy, hospital monitoring and informatics, as well as personal health.
